GL vs TGTX · P/E 10, rev $3.16B vs P/E 18, rev $240.3M
Globe Life Inc (GL) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Globe Life Inc (GL) is a insurance - life company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported GL revenue for 2026-06-30 was $3.16B. Net income was $558.3M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
GL currently screens at market cap $10.26B and trailing P/E 10.1. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the GL and TGTX stock pages for the full models.
Not investment advice.